NCT00154219View on ClinicalTrials.gov

Efficacy and Safety Study of Lumiracoxib in Patients With Primary Hip Osteoarthritis

PHASE3CompletedINTERVENTIONAL
Enrollment

1,200

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

October 31, 2006

Conditions
Osteoarthritis, Hip
Interventions
DRUG

Lumiracoxib (drug)

Trial Locations (5)

07936

For US Site Information, contact Novartis Pharmaceuticals, East Hanover

Unknown

Various Sites, Multiple Cities

Various Sites, Multiple Cities

Various Sites, Multiple Cities

Various Sites, Multiple Cities

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY